Medical treatment for symptomatic Benign Prostatic Hyperplasia (BPH) has become popular for the last few years. This study was designed to find out and compare the efficacy of terazosin, a at adrenoceptor blocker and finasteride, a Sa-reductase inhibitor in symptomatic BPH. Atotal of 60 patients (30 in terazosin group and 30 finasteride group) of symptomatic BPH were selected. Terazosin group received 1 mg daily at bedtime for 3 days, 2 mg at bedtime for 7 days, thereafter Smg at bedtime daily for 6 months. Finasteride group received S mg once daily.